Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1563916

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1563916

Cellular Health Testing

PUBLISHED:
PAGES: 184 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Cellular Health Testing Market to Reach US$6.5 Billion by 2030

The global market for Cellular Health Testing estimated at US$3.7 Billion in the year 2023, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Single-test Panels, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Multi-test Panels segment is estimated at 10.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$978.0 Million While China is Forecast to Grow at 8.0% CAGR

The Cellular Health Testing market in the U.S. is estimated at US$978.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Cellular Health Testing Market - Key Trends and Drivers Summarized

How Is Cellular Health Testing Transforming Biomedical and Clinical Research?

Cellular health testing is playing an increasingly critical role in biomedical and clinical research, offering deeper insights into how cells function, respond to treatments, and age. These tests assess various cellular functions, such as energy production, oxidative stress levels, and DNA damage, providing a comprehensive understanding of cell viability and vitality. Cellular health testing is widely used in research areas like oncology, metabolic disorders, and aging, where cellular function is central to disease progression. In cancer research, for instance, testing the health of tumor cells can help determine how they respond to treatments, guiding the development of more targeted therapies. Similarly, in the study of metabolic diseases, cellular health tests are used to monitor mitochondrial function, providing crucial information on how cells produce and manage energy. As the focus in medicine shifts toward preventative care and early intervention, cellular health testing is becoming a valuable tool for identifying underlying issues before they manifest as symptoms, leading to better outcomes for patients and more personalized approaches to healthcare.

Why Is Cellular Health Testing Critical in Drug Development and Disease Management?

Cellular health testing is essential for drug development and disease management because it allows researchers and clinicians to evaluate how cells respond to different therapeutic interventions, stressors, and environmental factors. In drug development, these tests are used to assess whether a drug enhances or impairs cellular function, offering early insights into its therapeutic potential or toxicity. Cellular health assays, which evaluate metrics like ATP production, reactive oxygen species (ROS) generation, and apoptosis, help determine whether a compound supports healthy cell function or triggers cell death. This is particularly important in oncology, where drugs aim to selectively kill cancer cells while sparing healthy ones. In chronic disease management, cellular health testing can be used to monitor disease progression by tracking changes in cellular metabolism, inflammation, or DNA integrity. For example, mitochondrial health tests are used in neurodegenerative diseases like Parkinson’s and Alzheimer’s to understand how cellular energy production declines over time, providing targets for potential therapeutic interventions. As healthcare moves towards more personalized approaches, cellular health testing will continue to be vital for monitoring individual responses to treatments and managing long-term health conditions.

How Are Technological Innovations Enhancing Cellular Health Testing?

Technological advancements are significantly enhancing the precision and scope of cellular health testing, enabling researchers to capture more detailed and dynamic data on cell function. One major breakthrough is the use of real-time imaging and live-cell analysis technologies, which allow scientists to monitor cellular health continuously over time without disrupting the cells. This has led to a better understanding of how cells behave under different conditions, such as drug exposure or oxidative stress, offering a more complete picture of cellular responses. High-throughput screening platforms have also revolutionized the field, enabling laboratories to conduct cellular health tests on thousands of samples simultaneously. These advancements are particularly valuable in drug discovery, where rapid, large-scale testing is essential for identifying promising therapeutic candidates. Additionally, advances in metabolomics and single-cell analysis technologies are providing more granular data on cellular health by measuring metabolic changes and assessing the health of individual cells within a population. With the rise of 3D cell cultures and organ-on-a-chip technologies, cellular health testing is also becoming more relevant for modeling complex tissues and organs, making it possible to study cell behavior in more physiologically relevant environments. These innovations are pushing the boundaries of what is possible in cellular health testing, leading to more accurate and actionable insights.

What Are the Key Factors Growth in the Cellular Health Testing Market?

The growth in the cellular health testing market is driven by several factors, including the rising demand for personalized medicine, the increasing focus on preventative healthcare, and advancements in testing technologies. One of the key drivers is the growing recognition that cellular health is a critical indicator of overall health and disease risk, which has led to greater adoption of these tests in both research and clinical settings. As healthcare shifts towards more individualized approaches, cellular health testing is becoming a cornerstone of personalized medicine, helping doctors and researchers understand how a patient’s cells function and respond to treatments on a more personal level. Technological innovations, such as real-time cell analysis, high-throughput testing platforms, and advanced imaging techniques, are making cellular health testing more accessible and efficient, driving its use in drug discovery and development. The rising prevalence of chronic diseases like diabetes, cardiovascular conditions, and neurodegenerative disorders is also contributing to market growth, as these conditions often involve disruptions in cellular function. Moreover, consumer interest in wellness and longevity has led to a growing demand for cellular health testing as a tool for monitoring aging and developing strategies to improve long-term health. With increasing investment in life sciences research, expanding applications in clinical diagnostics, and the growing use of cellular health tests in therapeutic development, the market for cellular health testing is expected to experience robust growth in the coming years.

Select Competitors (Total 22 Featured) -

  • Bio-Reference Laboratories, Inc.
  • Cell Science Systems Corp.
  • Cleveland Heartlab, Inc.
  • Dna Labs India
  • Genova Diagnostics
  • Immundiagnostik AG
  • Laboratory Corporation of America Holdings
  • Life Length
  • Quest Diagnostics, Inc.
  • Repeat Diagnostics Inc. (Repeat Dx)
  • Segterra, Inc.
  • SpectraCell Laboratories, Inc.
  • Telomere Diagnostics, Inc. (Tdx)
  • Zimetry LLC
Show more
Product Code: MCP10955

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cellular Health Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Preventive Healthcare Propels Growth in Cellular Health Testing Market
    • Advancements in Biomarker Discovery Expand Addressable Market Opportunity for Cellular Health Diagnostics
    • Increasing Focus on Longevity and Aging Research Strengthens Business Case for Cellular Health Testing
    • Innovations in Genomic and Proteomic Testing Spur Growth in Cellular Health Assessments
    • Rising Interest in Nutritional Genomics and Lifestyle Medicine Accelerates Demand for Cellular Health Monitoring
    • Increasing Use of Cellular Health Testing in Chronic Disease Management Sustains Market Growth
    • Shift Towards Home-Based and Remote Health Monitoring Expands Market Accessibility for Cellular Health Tests
    • Advances in Mitochondrial Function Testing Throw the Spotlight on Cellular Energy and Health Diagnostics
    • Increasing Adoption of Cellular Health Testing in Functional Medicine Practices Spurs Market Expansion
    • Growing Investments in Biotechnology and Diagnostics Drive Innovation and New Product Development in Cellular Health Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cellular Health Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cellular Health Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Single-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Single-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Multi-test Panels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Multi-test Panels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Blood Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Blood Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Sample Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Sample Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for At-home by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for At-home by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for In-office by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for In-office by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Collection Sites by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Collection Sites by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • JAPAN
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • CHINA
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • EUROPE
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Cellular Health Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Cellular Health Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • FRANCE
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • GERMANY
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cellular Health Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Cellular Health Testing by Type - Single-test Panels and Multi-test Panels Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of World 16-Year Perspective for Cellular Health Testing by Type - Percentage Breakdown of Value Sales for Single-test Panels and Multi-test Panels for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Cellular Health Testing by Sample Type - Blood Samples and Other Sample Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of World 16-Year Perspective for Cellular Health Testing by Sample Type - Percentage Breakdown of Value Sales for Blood Samples and Other Sample Types for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Cellular Health Testing by Collection Site - At-home, In-office and Other Collection Sites Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Cellular Health Testing by Collection Site - Percentage Breakdown of Value Sales for At-home, In-office and Other Collection Sites for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!